As an illustration, it has been demonstrated that high-dose CsA—although not reduced dose CsA—directly inhibits the expression of NFATc1 and IL-two in human T cells from stimulated complete blood samples, assessed by flow cytometry (23). Thus, compared with other cytotoxic immune suppressors, CsA isn't going to kill the immune effector https://garyl665whs8.illawiki.com/user